Diannei Bio launches its latest AI technology and medical testing solutions to help narrow the gap in domestic medical resources

2023-05-11 04:07:38

In recent years, the artificial intelligence industry has embarked on a path of rapid development. With the help of big data, Internet and other high-tech technologies, AI has unknowingly penetrated into all aspects of human life. From cars to robots, from home to retail, from transportation to medical care, artificial intelligence is almost everywhere. Among these wide-ranging applications, the application of artificial intelligence in the medical field has attracted people's attention.

At the 2018 China (Shanghai) International Artificial Intelligence Exhibition, Diannei (Shanghai) Biotechnology Co., Ltd. demonstrated its latest AI technology and medical testing solutions. As a start-up company, Point Nei Bio uses big data and artificial intelligence technology to carry out early lung cancer screening to help people find and prevent early tumors. At present, the company has completed an angel round of financing of nearly 10 million RMB.

In-point biological booth

At this exhibition, Diannei Biological demonstrated its latest product using artificial intelligence for early lung cancer screening, which can quickly and accurately assess the risk of lung cancer in patients. In an interview, Ge Liang, CEO of Diannet Technology, said that in the traditional medical industry, the pain points of uneven resources are obvious. For example, domestic top three hospitals have better resources, such as experienced and top international doctors, so as to ensure The patient gets the best treatment. However, in some district and county-level hospitals, although the equipment is not very different from that of large hospitals, the experience of the film-reading doctor may be insufficient. In this regard, with the help of artificial intelligence, we can narrow the gap between such medical resources. In other words, artificial intelligence can solve the problem of uneven medical resources to a certain extent, so that patients in district and county hospitals can also receive fast and accurate treatment.

No matter in which field, the application of artificial intelligence is inseparable from the support of big data, and it is no exception in the medical field. The lung testing products developed by Point Nei Biotech need to collect various cases and analyze data to ensure the accuracy of the test results. But most of the medical data is confidential. What method should be used to collect the data in order to improve the accuracy of the detection equipment? In this regard, Ge Liang said that the State Council issued a "Administrative Measures for Further Strengthening of China's Medical and Health Information Big Data" in June 2017. In this measure, the management standards for health information are mentioned. Inner Biosciences will comply with these standards. To collect information.

At present, the lung cancer screening products developed by Diannei Bio have been unanimously recognized by the market. In the future, Diannei Bio will continue to explore the innovative application of AI technology in the medical field, and plans to carry out various clinical applications in the field of oncology.

5 Wire Resistive Touch Screen

Our 5 wire resistive Touch Screen is the highest accuracy ,stable ,no effect to touch when the liquid pouring or spilling.And it is widely use to Industrial,Retail,

Transportation ,Finance,Hospital or other area.

5 wire touch screen have the following advantages,we worthy of your trust.

1) Can withstand more than 5,000,000 points.

2) 4096x4096 Resolution.

3) USB or RS232 Interface.

4) High accuracy and sensitivity.

5) Glass + Film Material.

6) Finger and touch pen activation.

7) Our products have passed CE, FCC, RoHS certification!

pictures show:

5 Wire Touch Screen Panel